• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

在一名患有慢性肢体威胁性缺血且有膝下截肢病史的患者中，药物涂层球囊血管成形术后出现的无血流现象。

The no-flow phenomenon following drug-coated balloon angioplasty in a patient with chronic limb-threatening ischemia and a history of below-knee amputation.

作者信息

Sobajima Mituso, Imamura Teruhiko, Fukuo Atsuko, Ueno Yohei, Onoda Hiroshi, Ueno Hiroshi, Kinugawa Koichiro

机构信息

The Second Department of Internal Medicine, Graduate School of Medicine, University of Toyama, Toyama, Japan.

出版信息

J Cardiol Cases. 2023 Mar 1;27(3):132-135. doi: 10.1016/j.jccase.2022.12.002. eCollection 2023 Mar.

DOI:10.1016/j.jccase.2022.12.002
PMID:36910034
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9995684/
Abstract

UNLABELLED

The endovascular treatment using a drug-coated balloon (DCB) reduces restenosis and target vessel re-vascularization rate in patients with peripheral artery disease such as claudication and chronic limb-threatening ischemia (CLTI). However, its safety and efficacy in patients with post-below-knee amputation remain unknown. We had a patient with CLTI and a history of below-knee amputation, who suffered a no-flow phenomenon following DCB angioplasty that required above-knee amputation. DCB angioplasty might not be appropriate for those with severe CLTI and histories of amputation.

LEARNING OBJECTIVE

The present report describes the risk of endovascular treatment using a drug-coated balloon for chronic limb-threatening ischemia patients with a below-knee amputated limb.

摘要

未标注

使用药物涂层球囊（DCB）进行血管内治疗可降低外周动脉疾病（如间歇性跛行和慢性肢体威胁性缺血（CLTI））患者的再狭窄率和靶血管再血管化率。然而，其在膝下截肢患者中的安全性和有效性尚不清楚。我们有一名患有CLTI且有膝下截肢病史的患者，在DCB血管成形术后出现无血流现象，需要进行膝上截肢。DCB血管成形术可能不适用于患有严重CLTI和截肢病史的患者。

学习目标

本报告描述了使用药物涂层球囊对患有膝下截肢肢体的慢性肢体威胁性缺血患者进行血管内治疗的风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4094/9995684/6e8835af1d91/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4094/9995684/4bc3d7cbc1f2/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4094/9995684/377ee79f09b8/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4094/9995684/6e8835af1d91/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4094/9995684/4bc3d7cbc1f2/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4094/9995684/377ee79f09b8/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4094/9995684/6e8835af1d91/gr3.jpg

相似文献

1
The no-flow phenomenon following drug-coated balloon angioplasty in a patient with chronic limb-threatening ischemia and a history of below-knee amputation.在一名患有慢性肢体威胁性缺血且有膝下截肢病史的患者中，药物涂层球囊血管成形术后出现的无血流现象。
J Cardiol Cases. 2023 Mar 1;27(3):132-135. doi: 10.1016/j.jccase.2022.12.002. eCollection 2023 Mar.
2
Comparative 12-Month Outcomes of Drug-Coated Balloon Versus Non-Drug-Coated Balloon Revascularization Strategy in Chronic Limb-Threatening Ischemia: Results From the XLPAD Registry.药物涂层球囊与非药物涂层球囊血管重建策略在慢性肢体威胁性缺血中的 12 个月比较结果：来自 XLPAD 登记处的结果。
Cardiovasc Revasc Med. 2020 Oct;21(10):1276-1284. doi: 10.1016/j.carrev.2020.03.030. Epub 2020 Mar 27.
3
Safety and Efficacy of Drug-Coated Balloon Angioplasty for the Treatment of Chronic Limb-Threatening Ischemia: A Systematic Review and Meta-Analysis.药物涂层球囊血管成形术治疗慢性肢体威胁性缺血的安全性和有效性：一项系统评价和荟萃分析。
J Endovasc Ther. 2020 Aug;27(4):647-657. doi: 10.1177/1526602820931559. Epub 2020 Jun 7.
4
Roles of Angioplasty With Drug-Coated Balloon for Chronic Ischemia in Wound Healing.药物涂层球囊血管成形术在慢性缺血性创面愈合中的作用。
J Endovasc Ther. 2021 Oct;28(5):778-787. doi: 10.1177/15266028211025023. Epub 2021 Jun 21.
5
Efficacy and safety of adjunctive drug-coated balloon therapy in endovascular treatment of common femoral artery disease.药物涂层球囊辅助治疗股总动脉疾病的血管内治疗的疗效和安全性。
Cardiovasc Revasc Med. 2019 Mar;20(3):210-214. doi: 10.1016/j.carrev.2018.06.018. Epub 2018 Jun 25.
6
Frequency, predictors, and effect of the slow-flow phenomenon after drug-coated balloon angioplasty for femoropopliteal lesions.股腘动脉病变药物涂层球囊血管成形术后慢血流现象的频率、预测因素及其影响。
Heart Vessels. 2021 Dec;36(12):1818-1824. doi: 10.1007/s00380-021-01871-6. Epub 2021 May 29.
7
The IN.PACT DEEP Clinical Drug-Coated Balloon Trial: 5-Year Outcomes.《IN.PACT DEEP 临床药物涂层球囊试验：5 年结果》
JACC Cardiovasc Interv. 2020 Feb 24;13(4):431-443. doi: 10.1016/j.jcin.2019.10.059.
8
Slow-flow phenomena following lower limb paclitaxel- and sirolimus-coated balloon angioplasty in the setting of chronic limb threatening ischaemia-a case series.慢性肢体威胁性缺血情况下下肢紫杉醇和西罗莫司涂层球囊血管成形术后的慢血流现象——病例系列
Quant Imaging Med Surg. 2022 Mar;12(3):2058-2065. doi: 10.21037/qims-21-633.
9
Major adverse limb events in patients with femoro-popliteal and below-the-knee peripheral arterial disease treated with either sirolimus-coated balloon or standard uncoated balloon angioplasty: a structured protocol summary of the "SirPAD" randomized controlled trial.接受西罗莫司涂层球囊或标准未涂层球囊血管成形术治疗的股腘动脉和膝下外周动脉疾病患者的主要肢体不良事件：“SirPAD”随机对照试验的结构化方案摘要。
Trials. 2022 Apr 21;23(1):334. doi: 10.1186/s13063-022-06242-8.
10
Outcomes of Drug-Coated Balloon Angioplasty vs. Conventional Balloon Angioplasty for Endovascular Treatment of Common Femoral Artery Atherosclerotic Disease.药物涂层球囊血管成形术与传统球囊血管成形术治疗股总动脉粥样硬化性疾病的血管内治疗结果比较。
Cardiovasc Revasc Med. 2020 Jul;21(7):867-874. doi: 10.1016/j.carrev.2019.11.008. Epub 2019 Nov 10.

本文引用的文献

1
Roles of Angioplasty With Drug-Coated Balloon for Chronic Ischemia in Wound Healing.药物涂层球囊血管成形术在慢性缺血性创面愈合中的作用。
J Endovasc Ther. 2021 Oct;28(5):778-787. doi: 10.1177/15266028211025023. Epub 2021 Jun 21.
2
Frequency, predictors, and effect of the slow-flow phenomenon after drug-coated balloon angioplasty for femoropopliteal lesions.股腘动脉病变药物涂层球囊血管成形术后慢血流现象的频率、预测因素及其影响。
Heart Vessels. 2021 Dec;36(12):1818-1824. doi: 10.1007/s00380-021-01871-6. Epub 2021 May 29.
3
Risk of Death and Amputation with Use of Paclitaxel-Coated Balloons in the Infrapopliteal Arteries for Treatment of Critical Limb Ischemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
紫杉醇涂层球囊在治疗严重肢体缺血的腘动脉以下动脉中的应用与死亡和截肢风险：一项随机对照试验的系统评价和荟萃分析。
J Vasc Interv Radiol. 2020 Feb;31(2):202-212. doi: 10.1016/j.jvir.2019.11.015. Epub 2020 Jan 15.
4
Outcomes After Drug-Coated Balloon Treatment of Femoropopliteal Lesions in Patients With Critical Limb Ischemia: A Post Hoc Analysis From the IN.PACT Global Study.药物涂层球囊治疗严重肢体缺血患者股腘动脉病变后的结局：来自IN.PACT全球研究的事后分析
J Endovasc Ther. 2019 Jun;26(3):305-315. doi: 10.1177/1526602819839044. Epub 2019 Apr 1.
5
Comparison of Particulate Embolization after Femoral Artery Treatment with IN.PACT Admiral versus Lutonix 035 Paclitaxel-Coated Balloons in Healthy Swine.健康猪中IN.PACT Admiral与Lutonix 035紫杉醇涂层球囊治疗股动脉后颗粒栓塞的比较。
J Vasc Interv Radiol. 2016 Nov;27(11):1676-1685.e2. doi: 10.1016/j.jvir.2016.06.036. Epub 2016 Sep 15.
6
Downstream Panniculitis Secondary to Drug-Eluting Balloon Angioplasty.药物洗脱球囊血管成形术继发的下游脂膜炎
JACC Cardiovasc Interv. 2016 Sep 12;9(17):e177-9. doi: 10.1016/j.jcin.2016.06.017. Epub 2016 Aug 17.
7
Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial.药物涂层球囊与标准经皮腔内血管成形术治疗股浅动脉和腘动脉外周动脉疾病：IN.PACT SFA随机试验的12个月结果
Circulation. 2015 Feb 3;131(5):495-502. doi: 10.1161/CIRCULATIONAHA.114.011004. Epub 2014 Dec 3.
8
Vasculitis resulting from a superficial femoral artery angioplasty with a paclitaxel-eluting balloon.由紫杉醇洗脱球囊行股浅动脉血管成形术后引起的血管炎。
J Vasc Surg. 2014 Feb;59(2):520-3. doi: 10.1016/j.jvs.2013.03.013. Epub 2013 May 1.